Vimnerixin (AZD4721) is the potent and orally active antagonist of acidic CXC chemokine receptor 2 ( CXCR2 ). Vimnerixin has the potential for the research of inflammatory disease.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > CXCR
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.